Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Phase I trial results support further development of SAN-300 for rheumatoid arthritis

Oct. 31, 2013

Fast clinical responses seen with clazakizumab in patients with rheumatoid arthritis

Oct. 31, 2013

Pharmacodynamic activity seen for AMG-811 in patients with SLE

Oct. 30, 2013

Researchers at Apac Pharmaceutical synthesize novel agents for arthritis

Oct. 30, 2013

Etanercept biosimilar product meets primary endpoint in pivotal study

Oct. 30, 2013

Hasselt University and Inova Diagnostics collaborate on biomarkers for RA

Oct. 30, 2013

Novel SYK inhibitor HM-0523 proves effective as antiarthritic drug in preclinical models

Oct. 29, 2013

Amgen divulges novel PI3Kdelta inhibitors

Oct. 29, 2013

Five Prime provides update on two antibody candidates entering phase I trials

Oct. 28, 2013

Epirus and Orygen Biotecnologia sign collaboration agreement for biotechnology products in Brazil

Oct. 24, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...